Sudarshan Pharma, a company in the Specialty Chemicals industry, reported revenue of ₹217 crore and net profit of ₹7.78 crore for the September 2026 quarter.
Sudarshan Pharma (NSE: SUDARSHAN) closed at ₹29.90 on 20 Nov 2026. Its market capitalisation is ₹761 crore and it trades at 26.2 times earnings.
Incorporated in 2008, Sudarshan Pharma Industries Ltd manufactures API and Pharmaceutical Items. It also trades in Chemicals and Solvents
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.